Increased mu opioid receptor binding detected by PET in cocaine−dependent men is associated with cocaine craving

The endogenous opioid system has been recently implicated in the reinforcing actions of cocaine and other addictive drugs. In this study we examined opioid receptor binding in ten cocaine−dependent men and seven nonaddicted controls using positron emission tomography and [¹¹C]carfentanil. Mu opioid binding was increased in several brain regions of the cocaine addicts studied 1−4 days after their last use of cocaine. Binding was positively correlated with the severity of cocaine craving experienced at the time. The upregulation of opioid receptor binding persisted after 4 weeks of monitored cocaine abstinence. These findings demonstrate for the first time the involvement of the endogenous opioid system in cocaine dependence and cocaine craving in living human subjects.

1. Ritz, M.C., Lamb, R.J., Goldberg, S.R. & Kuhar, M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219−1223 (1987). | PubMed  | ISI | ChemPort |
2. Hurd, Y.L., Weiss, F., Koob, G.F., And, N.-E. & Ungerstedt, U. Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: An in vivo microdialysis study. Brain Res. 498, 199−203 (1989). | Article | PubMed  | ISI | ChemPort |
3. Bain, G.T. & Kornetsky, C. Naloxone attenuation of the effect of cocaine on rewarding self-stimulation. Life Sci. 40, 1119−1125 (1987). | Article | PubMed  | ISI | ChemPort |
4. Steiner, H. & Gerfen, C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13, 5066−5081 (1993). | PubMed  | ISI | ChemPort |
5. Kalivas, P.W., Widerlov, E., Stanley, D., Breese, G. & Prang, A.J.J. Enkephaline action on the mesolimbic system: A dopamine-dependent and a dopamine-independent increase in locomotor activity. J. Pharmacol. Exp. Thar. 227, 229−237 (1983). | ChemPort |
6. Schulz, R., Wüster, M., Duka, T. & Herz, A. Acute and chronic ethanol treatment changes endorphine levels in brain and pituitary. Psychopharmacology 68, 221−227 1980). | PubMed  | ISI | ChemPort |
7. Carroll, M.E. & Lac, S.T. Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology 106, 439−550 (1992). | PubMed  | ISI | ChemPort |
8. Mello, N.K., Mendelson, J.H., Bree, M.P. & Lukas, S.E. Buprenorphine and nal-trexone effects on cocaine self-administration by rhesus monkeys. Science 245, 859−862 (1989). | PubMed  | ISI | ChemPort |
9. Tech, S.K., Melle, N.K., Mendelson, J.H., Kuehnle, J. & Gastfriend, D.R. Buprenorphine effects on heroin — and cocaine — induced subjective responses by drug dependent men. J. Clin. Pharmacol. 14, 15−77 (1994).
10. Schottenfeld, R.S., Pakes, J., Ziedonis, D. & Kosten, T.R. Dose-related effect on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol. Psychiatry 34, 66−74 (1993). | Article | PubMed  | ISI | ChemPort |
11. Johnson, R.E., Jaffe, J.H. & Fudala, P.J. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 267, 2750−2755 (1972).
12. Mannelli, P., Janiri, L., Tempesta, E. & Jones, R.T. Prediction in drug abuse: Cocaine interactions with alcohol and buprenorphine. Br. J. Psychiatry 163, 39−45 (1993). | ISI |
13. Unterwald, E.M., Home, K.J. & Kreek, M.J. Chronic cocaine alters brain mu opioid receptors. Brain Res. 584, 314−318 (1992). | Article | PubMed  | ISI | ChemPort |
14. Hammer, R.J. Cocaine alters opiate receptor binding in critical brain reward regions. Synapse 3, 55−60 (1989). | PubMed  | ISI | ChemPort |
15. Clow, D.W., Hammer, R.J., Kirstein, C.L. & Spear, L.P. Gestational cocaine exposure increases opiate receptor binding in weanling offspring. Dev. Brain Res. 59, 79−185 1991). | Article |
16. Hurd, Y.L. & Herkenham, M. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13, 357−369 (1993). | PubMed  | ISI | ChemPort |
17. Frost, J.J. et al. Imaging opiate receptors in the human brain by positron tomography. J. Comput. Assist. Tomogr. 9, 231−236 (1985). | PubMed  | ISI | ChemPort |
18. London, E.D. et al. Cocaine-induced reduction of glucose utilization in human brain: A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose. Arch. Gen. Psychiatry 47, 567−574 (1990). | PubMed  | ISI | ChemPort |
19. Volkow, N.D. et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am. J. Psychiatry 148, 621−626 (1991). | PubMed  | ISI | ChemPort |
20. Volkow, N.D., Mullani, N., Gould, K.L., Adler, S. & Krajewski, K. Cerebral blood flow in chronic cocaine users: A study with positron emission tomography. Br. J. Psychiatry 152, 641−648 (1988). | PubMed  | ISI | ChemPort |
21. Volkow, N.D. et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14, 169−177 (1993). | PubMed  | ISI | ChemPort |
22. Goodwin, G.A., Moody, C.A. & Spear, L.P. Prenatal cocaine exposure increases the behavioral sensitivity of neonatal rat pups to ligands active at opiate receptors. Neumtoxicol. Teratol. 15, 425−431 (1993). | Article | ChemPort |
23. Chen, J.F., Aloyo, V.J. & Weiss, B. Continuous treatment with the D₂ dopamine receptor agonist quinpirole decreases D₂, dopamine receptors, D₂, dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience 54, 669−680 (1993). | Article | PubMed  | ISI | ChemPort |
24. Hurd, Y.L. & Herkenham, M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol. Brain Res. 16, 97−104 (1992). | Article | PubMed  | ISI | ChemPort |
25. Frost, J.J. et al. Multicompartmental analysis of [¹¹C]carfentanil binding to opiate receptors in humans measured by positron emission tomography. J. Cereh. Blood Flow Metab. 9, 398−409 (1989). | ChemPort |
26. Robins, L.N., Helzer, J.E., Croughton, J. & Ratcliff, K.S. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics, and validity. Arch. Gen. Psychiatry 38, 381−389 (1981). | PubMed  | ISI | ChemPort |
27. McLellan, A.T., Luborsky, L., Woody, G.E. & O'Brien, C. An improved diagnostic evaluation instrument for substance abuse patients, the Addiction Severity Index. J. Nerv. Ment. Dis. 168, 26−33 (1980). | PubMed  | ISI | ChemPort |
28. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn., revised. [American Psychiatric Association (APA) Press, Washington, DC, 1987].
29. Halikas, J.A., Kuhn, K.L., Crosby, R., Carlson, G. & Crea, G. The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale. Compr. Psychiatry 32, 22−27 (1991). | Article | PubMed  | ISI | ChemPort |
30. Beck, A.T., Steer, R.A. & Garbin, M.G. Psychometric properties of the Beck: 25 years of evaluation. Clin. Psychol. Rev. 8, 77−100 (1988). | Article | ISI |
31. Meltzer, C.C. et al. Anatomical localization for PET using MR imaging. J. Comput. Assist. Tomogr. 14, 418−426 (1990). | PubMed  | ISI | ChemPort |
32. Dannals, R.F. et al. Radiosynthesis of an opiate receptor biding radiotracer: [¹¹C]Carfentanil. Int. J. Appl. Radiat. Isot. 36, 303−306 (1985). | Article | PubMed  | ISI | ChemPort |

	Top

	Top